LOS ANGELES -- (Business Wire)
Goldberg
Law PC, a national shareholder rights litigation firm, announces
that it is investigating Ophthotech Corporation (“Ophthotech” or the
“Company”) (Nasdaq: OPHT) concerning possible violations of federal
securities laws. Investors, who purchased or otherwise acquired
Ophthotech shares between May 11, 2015 and December 12, 2016 inclusive
(the “Class Period”), are encouraged to contact the firm prior to March
13, 2017, also known as the lead plaintiff motion deadline
If you purchased or otherwise acquired Ophthotech shares and would like
more information regarding the investigation, we encourage you to click
here, or contact Michael
Goldberg or Brian Schall,
of Goldberg Law PC, 1999 Avenue of the Stars Suite 1100, Los Angeles, CA
90067, at 800-977-7401, to discuss your rights without cost to you. You
can also reach us through the firm’s website at http://www.Goldberglawpc.com,
or by email at info@goldberglawpc.com.
According to the Complaint, Ophthotech rendered exaggerated positive
reports regarding the effectiveness and potential of its treatment
Fovista, used in combination with Lucentis, an anti-vascular endothelial
growth factor agent, despite knowledge that the phase 3 clinical trial
of Fovista would be unsuccessful in achieving its primary endpoint.
According to the Complaint, these statements caused Ophthotech stock to
trade at artificially inflated prices. On December 12, 2016, Ophthotech
revealed that the trial could not achieve its primary endpoint. When
this information was released to the public, the value of Ophthotech
stock fell sharply, causing investors severe harm.
If you have any questions concerning your legal rights, please
immediately contact Goldberg Law PC at 800-977-7401, or visit our
website at http://www.Goldberglawpc.com,
or email us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes
in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170119006346/en/
Contacts:
Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian
Schall, Esq., 800-977-7401
info@goldberglawpc.com
http://www.Goldberglawpc.com
Source: Goldberg Law PC
© 2024 Canjex Publishing Ltd. All rights reserved.